Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
In Situ Bone Tissue Engineering Using Gene Delivery Nanocomplexes Publisher Pubmed



Malekkhatabi A1 ; Javar HA1 ; Dashtimoghadam E2 ; Ansari S3 ; Hasanisadrabadi MM3, 4, 5 ; Moshaverinia A3, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, 1417614411, Tehran, Iran
  2. 2. Department of Chemistry, University of North Carolina, Chapel Hill, 27599-3220, NC, United States
  3. 3. Weintraub Center for Reconstructive Biotechnology, Division of Advanced Prosthodontics, School of Dentistry, University of California, Los Angeles, United States
  4. 4. California NanoSystems Institute, University of California, Los Angeles, United States
  5. 5. Department of Bioengineering, University of California, Los Angeles, United States

Source: Acta Biomaterialia Published:2020


Abstract

Gene delivery offers promising outcomes for functional recovery or regeneration of lost tissues at cellular and tissue levels. However, more efficient carriers are needed to safely and locally delivery of genetic materials. Herein, we demonstrate microfluidic-assisted synthesis of plasmid DNA (pDNA)-based nanocomplexe (NC) platforms for bone tissue regeneration. pDNA encoding human bone morphogenesis protein-2 (BMP-2) was used as a gene of interest. Formation and fine-tuning of nanocomplexes (NCs) between pDNA and chitosan (CS) as carriers were performed using a micromixer platform. Flow characteristics were adjusted to tune mixing time and consequently size, zeta potential, and compactness of assembled NCs. Subsequently, NCs were immobilized on a nanofibrous Poly(ε-caprolactone) (PCL) scaffold functionalized with metalloprotease-sensitive peptide (MMP-sensitive). This construct can provide an environmental-sensitive and localized gene delivery platform. Osteogenic differentiation of bone marrow-derived mesenchymal stem cells (MSCs) was studied using chemical and biological assays. The presented results converge to indicate a great potential of the developed methodology for in situ bone tissue engineering using immobilized microfluidic-synthesized gene delivery nanocomplexes, which is readily expandable in the field of regenerative nanomedicine. Statement of significance: In this study, we demonstrate microfluidic-assisted synthesis of plasmid DNA (pDNA)-based nanocomplexes (NCs) platforms for bone tissue regeneration. We used pDNA encoding human bone morphogenesis protein-2 (BMP-2) as the gene of interest. Using micromixer platform nanocomplexes (NCs) between pDNA and chitosan (CS) were fabricated and optimized. NCs were immobilized on a nanofibrous polycaprolactone scaffold functionalized with metalloprotease-sensitive peptide. In vitro and in vivo assays confirmed the osteogenic differentiation of mesenchymal stem cells (MSCs). The obtained data indicated great potential of the developed methodology for in situ bone tissue engineering using immobilized microfluidic-synthesized gene delivery nanocomplexes, which is readily expandable in the field of regenerative nanomedicine. © 2020 Acta Materialia Inc.
Other Related Docs
9. Silk As a Potential Candidate for Bone Tissue Engineering, Journal of Controlled Release (2015)
11. Microfluidic Devices for Gene Delivery Systems, Biomedical Applications of Microfluidic Devices (2020)
14. Nanofiber Technology in the Ex Vivo Expansion of Cord Blood-Derived Hematopoietic Stem Cells, Nanomedicine: Nanotechnology# Biology# and Medicine (2018)
17. Importance of Dual Delivery Systems for Bone Tissue Engineering, Journal of Controlled Release (2016)
18. Prospects of Sirna Applications in Regenerative Medicine, International Journal of Pharmaceutics (2017)
23. Recent Advances on 3D-Printed Pcl-Based Composite Scaffolds for Bone Tissue Engineering, Frontiers in Bioengineering and Biotechnology (2023)